| Up
2006N-0105:
Agency Information Collection Activities: Proposed Collection; Comment
Request; Environmental Impact Considerations Part 25 (21 CFR Part
25)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| N1
|
|
|
| 03/28/2006
|
| FDA
|
| FDA
|
| 03/29/2006
|
| 15753-15756
|
| 05/30/2006
|
| txt
|
|
|
|
|
| Signature:
|
| SHUREN, JEFFREY
|
|
|
|
|
| C1
|
| 06/02/2006
|
| 06/02/2006
|
| Drug Industry
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Alice E. Till, PhD
| |
Top | Up
Page last updated
June 9, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
